Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

How our clients use DrugPatentWatch

Generated: May 26, 2017

DrugPatentWatch Database Preview

Details for Patent: 4,803,081

« Back to Dashboard

Summary for Patent: 4,803,081

Title: New pharmaceutical preparations with extended release
Abstract:An extended release perparation of an active compound with very low solubility containing the active compound dissolved or dispersed in a semi-solid or liquid non-ionic solubilizer and whereby the amount by weight of the solubilizer is at least equal to the amount by weight of the active compound as well as a process for the preparation thereof.
Inventor(s): Falk; Karl-Erik L. (Lindome, SE), Hugosson; Sven M. (Kungsbacka, SE), Rosinski; Adam (Molndal, SE), Sjogren; John A. (Molnlycke, SE)
Assignee: Aktiebolaget Hassle (Molndal, SE)
Application Number:07/034,500
Patent Claim Types:
see list of patent claims
Formulation; Compound; Process;

No matches for this query

Foreign Priority and PCT Information for Patent: 4,803,081

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
Sweden8601624Apr 11, 1986

International Patent Family for Patent: 4,803,081

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Austria76288► Subscribe
Australia602677► Subscribe
Australia7004387► Subscribe
Canada1304294► Subscribe
China1025150► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

For more information try a trial or see the database preview and plans and pricing

How our clients use DrugPatentWatch

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:

Google Plus